|
🐜
|
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.
23 auth.
T. Bevers,
B. Anderson,
E. Bonaccio,
S. Buys,
M. Daly,
P. Dempsey,
W. Farrar,
I. Fleming,
J. Garber,
Randall Harris,
...
A. Heerdt,
M. Helvie,
John G. Huff,
N. Khakpour,
S. Khan,
H. Krontiras,
G. Lyman,
E. Rafferty,
S. Shaw,
M. Smith,
T. Tsangaris,
Cheryl Williams,
T. Yankeelov
|
9 |
2009 |
9
🐜
|
|
🐜
|
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
43 auth.
P. Razavi,
Bob T. Li,
David N. Brown,
B. Jung,
E. Hubbell,
R. Shen,
W. Abida,
K. Juluru,
Ino de Bruijn,
C. Hou,
Oliver Venn,
R. Lim,
A. Anand,
T. Maddala,
S. Gnerre,
...
Ravi Vijaya Satya,
Qinwen Liu,
Ling Shen,
N. Eattock,
J. Yue,
A. Blocker,
M. Lee,
A. Sehnert,
Hui Xu,
M. Hall,
Angie Santiago-Zayas,
W. Novotny,
J. Isbell,
V. Rusch,
G. Plitas,
A. Heerdt,
M. Ladanyi,
D. Hyman,
David R. Jones,
M. Morrow,
Gregory Riely,
H. Scher,
C. Rudin,
M. Robson,
L. Diaz,
D. Solit,
A. Aravanis,
J. Reis-Filho
|
9 |
2019 |
9
🐜
|
|
🐜
|
The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection: A Follow-up Study of 4008 Procedures
13 auth.
A. Naik,
J. Fey,
M. Gemignani,
A. Heerdt,
L. Montgomery,
J. Petrek,
E. Port,
V. Sacchini,
L. Sclafani,
K. VanZee,
...
R. Wagman,
P. Borgen,
H. Cody
|
8 |
2004 |
8
🐜
|
|
🐜
|
Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.
31 auth.
T. Bevers,
M. Helvie,
E. Bonaccio,
K. Calhoun,
M. Daly,
W. Farrar,
J. Garber,
R. Gray,
C. Greenberg,
R. Greenup,
N. Hansen,
Randall Harris,
A. Heerdt,
T. Helsten,
L. Hodgkiss,
...
Tamarya L. Hoyt,
John G. Huff,
L. Jacobs,
C. Lehman,
B. Monsees,
B. Niell,
Catherine C. Parker,
M. Pearlman,
L. Philpotts,
L. B. Shepardson,
M. Smith,
M. Stein,
Lusine Tumyan,
Cheryl Williams,
Mary Anne Bergman,
Rashmi Kumar
|
8 |
2018 |
8
🐜
|
|
🐜
|
Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma.
8 auth.
M. Jochelson,
D. Dershaw,
Janice S. Sung,
A. Heerdt,
Cynthia M. Thornton,
C. Moskowitz,
...
J. Ferrara,
Elizabeth A. Morris
|
8 |
2013 |
8
🐜
|
|
🐜
|
Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion?
12 auth.
Nancy Klauber-DeMore,
L. Tan,
L. Liberman,
Stamatina Kaptain,
J. Fey,
P. Borgen,
...
A. Heerdt,
L. Montgomery,
M. Paglia,
J. Petrek,
H. Cody,
K. J. Zee
|
8 |
2000 |
8
🐜
|
|
🐜
|
MRI of occult breast carcinoma in a high-risk population.
7 auth.
E. Morris,
L. Liberman,
Doug Ballon,
M. Robson,
A. Abramson,
A. Heerdt,
...
D. Dershaw
|
8 |
2003 |
8
🐜
|
|
🐜
|
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study
14 auth.
A. Mamtani,
A. Barrio,
T. King,
K. V. Van Zee,
G. Plitas,
M. Pilewskie,
M. El-Tamer,
M. Gemignani,
A. Heerdt,
L. Sclafani,
...
V. Sacchini,
H. Cody,
S. Patil,
M. Morrow
|
8 |
2016 |
8
🐜
|
|
🐜
|
Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer.
10 auth.
L. Montgomery,
A. Thorne,
K. V. Van Zee,
J. Fey,
A. Heerdt,
M. Gemignani,
...
E. Port,
J. Petrek,
H. Cody,
P. Borgen
|
7 |
2002 |
7
🐜
|
|
🐬
|
Patient Reluctance Toward Tamoxifen Use for Breast Cancer Primary Prevention
E. Port,
L. Montgomery,
A. Heerdt,
P. Borgen
|
7 |
2001 |
7
🐬
|
|
🐜
|
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.
12 auth.
M. Robson,
D. Levin,
M. Federici,
Jaya M. Satagopan,
Faina Bogolminy,
A. Heerdt,
...
P. Borgen,
B. McCormick,
C. Hudis,
L. Norton,
J. Boyd,
K. Offit
|
7 |
1999 |
7
🐜
|
